STRUCTURAL AND FUNCTIONAL-ANALYSIS OF THE HUMAN VASOACTIVE-INTESTINAL-PEPTIDE RECEPTOR GLYCOSYLATION - ALTERATION OF RECEPTOR FUNCTION BY WHEAT-GERM-AGGLUTININ

被引:0
|
作者
CHOCHOLA, J
FABRE, C
BELLAN, C
LUIS, J
BOURGERIE, S
ABADIE, B
CHAMPION, S
MARVALDI, J
ELBATTARI, A
机构
[1] UNIV AIX MARSEILLE 1,INST CHIM BIOL,CNRS,URA 202,PL V HUGO,F-13331 MARSEILLE 3,FRANCE
[2] UNIV LIMOGES,INST BIOTECHNOL,F-87060 LIMOGES,FRANCE
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The vasoactive intestinal peptide (VIP) receptor from the human melanoma cell line IGR39 has been shown to be a 60-kDa glycoprotein. Using serial lectin affinity chromatography, as well as specific glycosidases, we demonstrate that VIP receptor-linked carbohydrates are predominantly tri- or tetraantennary sialylated N-linked oligosaccharides, 27% of which are fucosylated, and some may have terminal galactose residues. Treatment of I-125-VIP receptor complexes with peptide-N-(N-acetyl-beta-D-glucosaminyl)asparagine amidase revealed the presence of at least three N-linked carbohydrate chains/receptor polypeptide. To investigate the functional role of the carbohydrate moiety, I-125-VIP binding to IGR39 cell membranes was tested in the presence of soluble lectins. Among the lectins tested, only wheat germ agglutinin (WGA) was found to markedly inhibit VIP binding in a dose-dependent manner. Binding data indicated that the presence of the lectin led to a 3-fold increase in K(d) value, from 0.15 to 0.44 nM, without any change in the number of available binding sites. The potent inhibitor of WGA binding, N,N',N''-triacetvtchitotriose, completely reversed the effect of the lectin. On the other hand, VIP binding inhibition persisted even after neuraminidase treatment, suggesting that sialic acids were not directly involved. Furthermore, WGA inhibition was not abolished although most, if not all, VIP receptor oligosaccharides were converted to high mannose type structures by treating IGR39 cells with deoxymannojirimycin. Finally, whereas the pharmacological profile of VIP receptor was virtually identical, the presence of WGA greatly reduced the VIP-stimulated cAMP in IGR39 cells, indicating that the lectin alters the ability of the receptor to interact with the adenylate cyclase system.
引用
收藏
页码:2312 / 2318
页数:7
相关论文
共 45 条
  • [1] CLONING AND FUNCTIONAL EXPRESSION OF A HUMAN NEUROENDOCRINE VASOACTIVE-INTESTINAL-PEPTIDE RECEPTOR
    SREEDHARAN, SP
    PATEL, DR
    HUANG, JX
    GOETZL, EJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 193 (02) : 546 - 553
  • [2] VASOACTIVE-INTESTINAL-PEPTIDE RECEPTOR EXPRESSION ON HUMAN LYMPHOBLASTS
    ODORISIO, MS
    SHANNON, BT
    MULNE, AF
    ZWICK, D
    GROSSMAN, NJ
    RUYMANN, FB
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1992, 14 (02): : 144 - 150
  • [3] CLONING AND EXPRESSION OF THE HUMAN VASOACTIVE-INTESTINAL-PEPTIDE RECEPTOR
    SREEDHARAN, SP
    ROBICHON, A
    PETERSON, KE
    GOETZL, EJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) : 4986 - 4990
  • [4] CHARACTERIZATION OF THE HUMAN LIVER VASOACTIVE-INTESTINAL-PEPTIDE (VIP) RECEPTOR
    MEUNIER, AC
    CARRETIER, M
    ELBATTARI, A
    LUIS, J
    KARAMANOS, Y
    MULLER, JM
    BIOMEDICAL RESEARCH-TOKYO, 1992, 13 : 157 - 161
  • [5] MOLECULAR-CLONING OF THE HUMAN VASOACTIVE-INTESTINAL-PEPTIDE RECEPTOR
    SREEDHARAN, SP
    ROBICHON, A
    CHENG, P
    GOETZL, EJ
    FASEB JOURNAL, 1991, 5 (05): : A1227 - A1227
  • [6] CLONING AND FUNCTIONAL-CHARACTERIZATION OF THE HUMAN VASOACTIVE-INTESTINAL-PEPTIDE (VIP)-2 RECEPTOR
    ADAMOU, JE
    AIYAR, N
    VANHORN, S
    ELSHOURBAGY, NA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 209 (02) : 385 - 392
  • [7] MOLECULAR-CLONING AND FUNCTIONAL-CHARACTERIZATION OF A HUMAN LIVER VASOACTIVE-INTESTINAL-PEPTIDE RECEPTOR
    GAGNON, AW
    AIYAR, N
    ELSHOURBAGY, NA
    CELLULAR SIGNALLING, 1994, 6 (03) : 321 - +
  • [8] SPECIFIC RECOGNITION OF THE HUMAN NEUROENDOCRINE RECEPTOR FOR VASOACTIVE-INTESTINAL-PEPTIDE BY ANTIPEPTIDE ANTIBODIES
    GOETZL, EJ
    PATEL, DR
    KISHIYAMA, JL
    SMOLL, AC
    TURCK, CW
    LAW, NM
    ROSENZWEIG, SA
    SREEDHARAN, SP
    MOLECULAR AND CELLULAR NEUROSCIENCE, 1994, 5 (02) : 145 - 152
  • [9] HUMAN INTRAEPITHELIAL LYMPHOCYTES - IMMUNOMODULATION AND RECEPTOR-BINDING OF VASOACTIVE-INTESTINAL-PEPTIDE
    ROBERTS, AI
    PANJA, A
    BROLIN, RE
    EBERT, EC
    DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (03) : 341 - 346
  • [10] VASOACTIVE-INTESTINAL-PEPTIDE IN BOVINE PULMONARY-ARTERY - LOCALIZATION, FUNCTION AND RECEPTOR AUTORADIOGRAPHY
    BARNES, PJ
    CADIEUX, A
    CARSTAIRS, JR
    GREENBERG, B
    POLAK, JM
    RHODEN, K
    BRITISH JOURNAL OF PHARMACOLOGY, 1986, 89 (01) : 157 - 162